| abstract |
Bicyclic heterocyclic compounds of formula (I), tautomers, stereoisomers and salts of said compounds, in particular physiologically acceptable salts with inorganic or organic acids or bases having valuable pharmacological properties, in particular the transduction-inhibiting activity of tyrosine kinase-mediated signals; the use of said bicyclic heterocyclic compounds for the treatment of diseases, in particular tumor diseases, pulmonary diseases and airway diseases, and the preparation of said compounds. |